Case File
efta-efta01069456DOJ Data Set 9OtherIESIOSIERONE
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01069456
Pages
1
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
IESIOSIERONE
For many that gamble is the
possibility of side effeCtS. A study
and subsequent article in the BMJ
questioned the data behind the NICE
recommendations, warning that some
trials included in the analysis were
funded by statin manufacturers and
that data on side effects was lacking.
Patients taking statins often
anecdotally report muscle pain.
although this has not been seen in the
major, placebo-controlled trials. The
BM] article said that one in five people
on statins experiences a side effect of
some kind, altnough It later withdrew
this claim after Rory Collins at the
University of Oxford, a leading statin
researcher. spoke out against the
fat EVEI? heart attack prevented,
accuracy of the statistics.
Yet the anecdotal reports continue
mote people will be toil statics
to surface. -Some doctors say they
keep seeing patients with the same
complaint and they feel its due to the
stab n: says David Preiss of the
University 01 Glasgow. It doesn't look
that way from the trials. but we need
a better answer."
There does seem to be a link to
diabetes. Preiss has studied the
connection between statins and
type 2 diabetes. He says taking a
medium-dose statin raises your risk by
10 per cent. and the risk continues to
rase in line with dosage. These are
modest changes - people who are
probably already on the trajectory
to diabetes, and the stain pushes
them over the threshold."
In light of all the concerns.
Collins's.
undertaking a major renew of the
data on side effects, which he hopes
will reassure people. That's important,
he says, because fears over statins are
discouraging people from taking
them. to the detnrnent of their health.
The results should be out later this
year. In the meantime. if you've ever
had a heart attack or stroke, you should
be on a stain it possible, says Preiss.
"And if you haven't, but you've been
shown to be moderately or markedly
at risk of having a heart attack, the
benefits of a statin considerably
outweigh any risks."
No one should pin all their hopes on
a pill in any case. Taking stators should
be accompanied by lifestyle changes
such as taking exercise and giving up
smoking.
RO hBOCIII
. „
What they popped
The percentage of adults taking the commonest
types of prescription drugs is rising, according to
a US Survey
■ 1994.1798
MI 2007.2010
18.64 years
Antidepressants
Analgesics
Anticoaglants
Arthdiabetics
Anti-acid reflux
Cholesterol-Icnsering
Cardiovascular
65 years and over
antidepreSSants
AnalgeSics
Anticoagulants
Antidiabelics
Anti-acid reflux
Cholesterol-lowering
Cardiovascular
I
I
I
I.
6
LB
116
16.6
0
23
4.0
E3
80
Per cent
If the adverts arc to be believed. testosteron
supplements are a cure-all for men facings
unfortunate effects of middle age.lhe
hormone is claimed to improve muscle
strength, energy and sex drive. However, not
only is there little evidence for this, several
studies have found a link with heart disease.
Trad I t lonally, testosterone was prescribed
to men with abnormally low levels due to a
congenital condition or damage to the testes
from chemotherapy. Now, though, middle-
aged men are being prescribed "testosterone
replacement therapy" (T 'l') to make up for t
natural decline that often comes with age.
In the US, the number of men being
prescribed testosterone rose from 1.3 million
2.3 million in the five years up to 2013, and the
UK has seen a similar trend, although the
numbers are far lower (see graph, below right):
But in March. the US Food and Drug
Administration cautioned that testosterone
should only be prescribed to men with low
levels caused by medical conditions, rather
than general ageing, and confirmed by a lab
test. The European Medicines Agency has
issued a similar statement.
The health bodies also asked manufacturers
and prescribers of testosterone products to
warn users about a possible risk of heart
attacks and strokes after a number of studies
showed an association. One trial was even
term inated early due to an `excess of
cardiovascular events" among participants.
Worryingly, a 2013 analysis found that the level
of cardiovascular risk reported varied.
depending on whether the study was funded
by the pharmaceutical industry.
One possible mechanism for testosterone's
effect on the heart could be through raising
the number of red blood cells. which thickens
the blood and can lead to dangerous dotting.
Another worry is prostate cancer, which
feeds on testosterone: drugs blocking
testosterone are sometimes used to stop the
cancer spreading. A meta-analysis published
in 2014 found no link with Tat In the short
term. but called for more long-term data.
"There's an absence of data on the use of
testosterone outside its key clinical application
and yet someclinicianenthusiasts,
particularly private practitioners In the US.
have just exploded testosterone prescribing
to the point where it's almost become
mainstream." says Richard Qu inton. an
endocrinologist at Newcastle University, UK.
Pan of the problem. at least in the US, is that
men are not being properly tested before
start I ng treatment, says Sander Greenland all
epidemiologist at the University of California,
321NewSPentist 116 stay 2015
EFTA01069456
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.